|
Volumn 14, Issue 4, 1996, Pages 415-417
|
Phase II study of mitonafide in non-small cell lung cancer (NSCLC)
a b c a c b d d |
Author keywords
Mitonafide; Non small cell lung cancer; Phase II
|
Indexed keywords
MITONAFIDE;
ADULT;
AGED;
ALOPECIA;
ANEMIA;
ARTICLE;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COGNITION;
FEMALE;
HUMAN;
INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
LUNG NON SMALL CELL CANCER;
MALE;
MUCOSA INFLAMMATION;
NEUROTOXICITY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
VOMITING;
|
EID: 0030480451
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1007/BF00180820 Document Type: Article |
Times cited : (17)
|
References (7)
|